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Varicose Veins: Highlighting the Confusion over
How and Where to TreatVaricose veins affect up to a third of the adult population
in Western countries and around 90,000 varicose vein
operations are performed annually in England.1 Patients
may present for numerous reasons, ranging from aesthetic
concerns to severe pain and ulceration. The significant
impact on patient quality of life and health service expense
is beyond dispute, particularly for patients with chronic
venous hypertension and ulceration. The CEAP classifica-
tion (clinical, etiologic, anatomic, pathophysiological) can
be used to classify the severity of venous disease,2 and is
utilised by some to decide which patients should be offered
treatment. There is an unequivocal body of evidence
demonstrating that treatment of varicose veins results in
clinical and quality of life benefits for patients in all
CEAP categories.3e5 The quality of life benefits from vari-
cose vein surgery have been shown to match those from
elective laparoscopic cholecystectomy.6
Once a patient has been deemed suitable for treatment,
a plethora of treatment modalities may be offered depend-
ing on the clinician or hospital receiving the referral. For
patients with greater or lesser saphenous vein incompe-
tence, standard varicose vein surgery usually involves flush
disconnection and stripping of the refluxing vein and
avulsion of the prominent varicosities. This ‘traditional’
treatment is supported by decades of evidence and may be
considered the ‘gold standard’ for varicose vein treatment.
However, complications such as wound infection, bruising
and varicose vein recurrence due to technically inadequate
surgery or neovascularisation have been widely reported.7
The demand for smaller scars, fewer complications and
faster return to work has inspired a number of new treat-
ment options for varicose veins.
Modern, minimally invasive treatment options include
foam sclerotherapy and venous ablation with radiofre-
quency energy or laser.8e11 Foam sclerotherapy offers the
least invasive option as cannulation of the vein to be
treated represents the most painful part of the procedure.
Foam is then injected into the vein resulting in a localised
chemical thrombophlebitis and subsequent occlusion.
Both laser and radiofrequency ablation involve placement1078-5884/$34 ª 2008 European Society for Vascular Surgery. Publishe
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after infiltration of tumescent anaesthesia. The intended
result is closure of the venous channel. Patients with
tortuous, superficial or very small veins may be considered
unsuitable for endovenous ablation.
Each modality has enthusiastic advocates and promising
early results. However, reports of serious adverse events
including scotoma or stroke after foam sclerotherapy and
skin burns after laser/radiofrequency ablation have been
a cause of unease, particularly as the true incidence of
these and other complications remains unknown. With each
endovenous modality, treatment may be performed under
local anaesthesia in the setting of a clinic room. This
approach is likely to offer considerable financial and
logistic advantages and has been widely publicised, but
may involve multiple treatment sessions. Many clinicians
offering the new techniques prefer to perform procedures
under general anaesthesia in the operating theatre in order
to easily treat multiple veins and perform avulsions.
Whether patients prefer a ‘one-stop’ treatment under
general anaesthesia or multiple treatments under local
anaesthesia in an ‘office’ environment remains unknown.
The introduction of new less invasive treatments for
venous disease is undoubtedly welcome, but new choices
have added new confusion. The inevitable introduction of
further endovenous techniques in the future is likely to add
to the uncertainty. Unfortunately, there are few studies
directly comparing the different techniques, reporting long
term outcomes or evaluating cost effectiveness. Indeed, in
many cases a combination of surgical and endovenous
treatments may be offered, making it increasingly difficult
to ascertain the efficacy of treatment components. It is
likely that optimum venous treatment may involve a com-
bination of interventional techniques tailored to the in-
dividual patient, and those involved in the treatment of
venous disease should be able to offer a range of treatment
modalities.
After nearly a century of consistency, the treatment of
patients with venous disease is evolving rapidly. Clinicians
and researchers have a responsibility to continue reportingd by Elsevier Ltd. All rights reserved.
108 Editoriallong term clinical, quality of life and health economic data
from well conducted prospective studies to help clarify the
benefits and risks of the wide range of venous interventions
currently available.
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